HUM vs XLO · P/E 39, rev $129.66B vs rev $19.1M
Humana Inc (HUM) versus Xilio Development Inc (XLO) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported XLO revenue for 2025-09-30 was $19.1M. Net income was -$45.4M. XLO currently screens at market cap $55.3M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. XLO currently screens at market cap $55.3M.
Not investment advice. Open the HUM and XLO stock pages for the full models.
Not investment advice.